OTC Markets OTCPK - Delayed Quote USD

United Health Products, Inc. (UEEC)

0.1602 -0.0097 (-5.71%)
At close: June 7 at 2:48 PM EDT
Loading Chart for UEEC
DELL
  • Previous Close 0.1699
  • Open 0.1700
  • Bid 0.1601 x --
  • Ask 0.1700 x --
  • Day's Range 0.1602 - 0.1700
  • 52 Week Range 0.1600 - 0.4500
  • Volume 12,500
  • Avg. Volume 153,823
  • Market Cap (intraday) 39.719M
  • Beta (5Y Monthly) -0.29
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Aug 9, 2024 - Aug 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

uhpcorp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UEEC

Performance Overview: UEEC

Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

UEEC
27.18%
S&P 500
12.10%

1-Year Return

UEEC
11.49%
S&P 500
24.82%

3-Year Return

UEEC
84.89%
S&P 500
26.41%

5-Year Return

UEEC
80.93%
S&P 500
88.04%

Compare To: UEEC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UEEC

Valuation Measures

Annual
As of 6/7/2024
  • Market Cap

    39.69M

  • Enterprise Value

    40.39M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -418.27%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.93M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    80.88k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.5M

Research Analysis: UEEC

Company Insights: UEEC

Research Reports: UEEC

People Also Watch